3-hydroxychlormadinone Acetate For The Topical Treatment Of Androgen-dependent Skin Diseases

  • Published: Jul 3, 2008
  • Earliest Priority: Dec 22 2006
  • Family: 5
  • Cited Works: 2
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works Full text
Abstract

The invention relates to the use of 3ß-hydroxychlormadinone acetate (17a-acetoxy-chloropregna-4,6-dien-3ß-ol-20-one) and/or 3a-hydroxychlormadinone acetate (17a-acetoxy-chloropregna-4,6-dien-3a-ol-20-one) for the production fo a medicament for the treatment of the skin, preferably human skin by means of topical application and a pharmaceutical or cosmetic composition containing 3ß-hydroxychlormadinone acetate and/or 3a-hydroxychlormadinone acetate.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jul 3, 2008
  • Application: Dec 19, 2007
    WO EP 2007011144 W
  • Priority: Dec 22, 2006
    DE DE 102006062120 A

Download Citation


Sign in to the Lens

Feedback